ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2726

Severe Infections in Systemic Necrotizing Vasculitis: Incidence and Risk Factors

Claudia Elizabeth Pena1, Ana Carolina Costi2, Lucila Garcia3, Mariana Pera4 and Mercedes Garcia1, 1Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 2Rheumatology Section, HIGA General San Martin La Plata, La Plata, Argentina, 3HIGA General San Martin La Plata, La Plata, Argentina, 4HIGA General San Martin La Plata, la plata, Argentina

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ANCA, infection and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis – ANCA-Associated Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Infections in patients with systemic necrotizing vasculitis represent one of the main causes of mortality. Risk factors of infection such as corticosteroid use, intensity of immunosuppressive therapy , age, presence of leucopenia, lymphopenia,associated organic involvement, and dialysis dependence have been identified. Objective:To determine the incidence of infection in patients diagnosed with:Polyangeitis with Granulomatosis(GPA), Eosinophilic Polyangiitis with Granulomatosis(EGPA), Microscopic Polyangeitis(PAM) and Panarteritis Nodosa (PAN), b) clinical characteristics and associated risks factors

Methods: Retrospective study. Data source: clinical records of patients diagnosed with ANCA associated vasculitis and PAN, evaluated in a center of rheumatology (2000-2016). Variables:Demographic data, clinical manifestations, laboratory data, infectious events serious (requiring hospitalization or prolonged antibiotic/antiviral treatment, recurrences of herpes zoster virus or opportunistic infections), sites of infection, isolated microorganisms, mortality related to the infectious event.

Results: 80 patients, 61.25% women. Mean age at diagnosis: 49.2 years (range 18-77). Types of vasculitis: 41.2% GPA, 18.7% EPGA, 26.25% PAM, 3.73% PAN not associated with HBV and 10% ANCA-associated vasculitis that did not met classification criteria. Systemic involvement (68%), pulmonary (59%), renal (58%) and otorhinolaryngology (43.6%) were the most frequent. 36 infectious events were recorded in 28 patients. Follow-up time: Median 22 m (IQR6-64). Incidence of infection:38.4%, with a median of 3 m (IQR 1-18 m) from diagnosis of vasculitis . Low respiratory infections (40.7%), sepsis (39.3%), and urinary tract infections (15%) were the most common. 25% of these patients presented a second infectious event, being low respiratory tract the most frequent site (47%). Two patients had a 3rd event (soft tissue infection, septic shock). Bacterial etiology was the most prevalent (45%), being the microorganisms most frecuently isolated : Klebsiella Pneumoniae (25%), Acinetobacter spp( 19%) , E. coli and polymicrobial ( 12.5% respectively ). Overall mortality was 17.5% ( 14/80) and related infectious event : 50% (n=7). 71.4% of patients were in the induction phase of treatment. Immunosuppressants used prior to infectious event: cyclophosphamide (48.1%), azathioprine (11.1%), methotrexate (7.4%), mofetil mycophenolate (3.7%), none (22.2%). Corticosteroids ≥ 30 mg/d were observed in 35.7% patients, ranging from 7.5-30 mg/d (10.7%), and ≤7.5 mg /d in 35.7%. Presence of leukopenia (26%), lymphopenia (44%), hypoalbuminemia (24%), renal insufficiency (63%) and dialysis dependency (37%) were identified in patients with infectious events .Renal involvement (p0.01) and dialysis dependence (p0.001) were significantly associated with infection.

Conclusion: The incidencia of infection was 38.4%.Lower airway infections, septicemia and urinary tract infections were the most commonly implicated sites. Most infections occurred in the induction phases of the disease. Dialysis dependence and presence of renal involvement were significantly associated with this complication.


Disclosure: C. E. Pena, None; A. C. Costi, None; L. Garcia, None; M. Pera, None; M. Garcia, None.

To cite this abstract in AMA style:

Pena CE, Costi AC, Garcia L, Pera M, Garcia M. Severe Infections in Systemic Necrotizing Vasculitis: Incidence and Risk Factors [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/severe-infections-in-systemic-necrotizing-vasculitis-incidence-and-risk-factors/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/severe-infections-in-systemic-necrotizing-vasculitis-incidence-and-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology